Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: A consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation

Journal of Neurology

Volumn 247, Issue 5, 2000, Pages 376-382

  Comi, G ^a   Kappos, L ^b   Clanet, M ^c   Ebers, G ⁱ   Fassas, A ^d   Fazekas, F ^e   Filippi, M ^a   Hartung, H P ^e   Hertenstein, B ^f   Karussis, D ^g   Martino, G ^a   Tyndall, A ^b   Van Der Meche F G A ^h  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c CHU PURPAN   (France)

^d G PAPANICOLAOU HOSPITAL   (Greece)

^e UNIVERSITY OF GRAZ   (Austria)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ NONE

Author keywords

Consensus guidelines; Haemopoietic stem cell transplantation; Multiple sclerosis

Indexed keywords

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD AUTOTRANSFUSION; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MULTIPLE SCLEROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

BLOOD TRANSFUSION, AUTOLOGOUS; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTIPLE SCLEROSIS;

EID: 0034080038     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050605     Document Type: Article

References (26)

1. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ader HJ, Losseff N, Valk J (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059-2069
2. Blank M, Krause I, Lanir N, Vardi P, Gilburd B, Tincani A, Tomer Y, Shoenfeld Y (1995) Transfer of experimental antiphospholipid syndrome by bone marrow transplantation. The importance of T cells. Arthritis Rheum 38:115-122
3. Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D, Terry C, Lobeck L, Russell EJ, Goolsby C, Rosen S, Gordon LI, Keever-Taylor C, Brush M, Fishman M, Burns WH (1998) T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis - report on the first three patients. Bone Marrow Transpl 21:537-541
4. Comi G, Filippi M, for the Copaxone MRI Study Group (1999) The effect of glatiramer acetate (Copaxone®) on disease activity as measured by cerebral MRI in patients with relapsing-remitting multiple sclerosis (RRMS): a multi-center, randomized, double-blind, placebo-controlled study extended by open-label treatment. Neurology 52:A289
5. Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (1998) McAlpine's multiple sclerosis, 3rd edn. Churchill Livingstone, Edinburgh
6. Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M, Zander AR, Schalke B, Hahn U, Haas R, Schmitz N (1996) Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 88:3621-3625
7. European Study Group on Interferon beta-1b in Secondary Progressive MS (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet 352:1491-1497
8. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, Tsompanakou A (1997) Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transpl 20:631-638
9. Gelder M van, Bekkum DW van (1996) Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transpl 18:1029-1034
10. IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655-661
11. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH, Alam JJ, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE 3rd, Priore RL, Pullicino PM, Scherokman BJ, Whitham RH, et al. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 39:285-294
12. Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. Neurology 45:1268-1276
13. Kappos L (1997) Therapy. In: Kesselring J, McDonald WI (eds) Multiple sclerosis. Cambridge University Press, Boston, pp 148-167
14. Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A (1992) Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngenic bone marrow transplantation. J Immunol 148:1693-1698
15. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
16. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
17. Marmont AM, Tyndall A, Gratwohl A, Vischer T (1995) Haemopoietic precursor-cell transplants for autoimmune diseases. Lancet 345:978
18. Martin R, McFarland HF, McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187
19. McAllister LD, Beatty PG, Rose J (1997) Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transpl 19:395-397
20. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
21. Sipe JC, Knobler RL, Braheny SL, Rice GP, Panitch HS, Oldstone MB (1984) A neurologic rating scale (SNRS) for use in multiple sclerosis. Neurology 34:1368-1372
22. Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs P, Bergman J, Brooks PM, Biggs JC (1998) Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 41:453-459
23. Tyndall A, Gratwohl A (1997) Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transpl 19:643-645
24. Weinshenker BG (1995) The natural history of multiple sclerosis. Neurol Clin 3:119-146
25. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112:133-146
26. Weinshenker BG, Issa M, Baskerville J (1996) Meta-analysis of the placebo-treated groups in clinical trials of progressive MS. Neurology 46:1613-1619